Shorter Herceptin breast cancer treatment may produce better results

[News]

Breast cancer patients who receive the drug Herceptin for nine weeks as part of their post-surgery chemotherapy regime may enjoy better health outcomes, according to new research led by UCL...

More... (http://www.medicalnewstoday.com/releases/316170.php)